The Leadership Team at Silence Therapeutics Plc is responsible for setting the strategic direction and vision of the company, overseeing the development and execution of its RNA interference gene therapeutic technologies. This diverse team, consisting of leaders from technical operations, medical research, finance, drug discovery, and regulatory affairs, collaboratively drives innovation and ensures that projects align with business goals while navigating the complex landscape of biopharmaceutical development.
Barbara Ruskin
SVP, Chief Intellectual Proper...
Craig Tooman
President, CEO & Executive Dir...
Eric Floyd
SVP, Regulatory Affairs & Qual...
J.P. Gabriel
Chief Technical Operations Off...
John Strafford
SVP, Business Development, All...
Judith Hauptmann
Principal Scientist
Marie Wikström Lindh...
SVP & Head, Molecular Design
Rhonda Hellums
CFO
Steffen Schubert
Vice President Drug Discovery
Steven Romano
Chief Medical Officer and Head...
View all